RENAU.UNSP.ARD 1/5 EO-20 Market Cap ($17.02 Billion)
Market Cap & Net Worth: RENAU.UNSP.ARD 1/5 EO-20 (56S0)
RENAU.UNSP.ARD 1/5 EO-20 market cap. RENAU.UNSP.ARD 1/5 EO-20 (F:56S0) has a market capitalization of $17.02 Billion (€14.56 Billion) as of October 31, 2026. Listed on the F stock exchange, this Germany-based company holds position #1432 globally and #324 in its home market, demonstrating a 5.71% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying RENAU.UNSP.ARD 1/5 EO-20's stock price €22.20 by its total outstanding shares 972808450 (972.81 Million).
RENAU.UNSP.ARD 1/5 EO-20 Market Cap History (2022–2026)
RENAU.UNSP.ARD 1/5 EO-20 market cap history from 2022 to 2026. Data shows change from $33.61 Billion to $25.25 Billion (-8.75% CAGR). Check 56S0 live share price for real-time trading data and today's change.
RENAU.UNSP.ARD 1/5 EO-20 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how RENAU.UNSP.ARD 1/5 EO-20's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see 56S0 cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
7.82x
RENAU.UNSP.ARD 1/5 EO-20's market cap is 7.82 times its annual revenue
Latest Price to Earnings (P/E) Ratio
87.35x
RENAU.UNSP.ARD 1/5 EO-20's market cap is 87.35 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $33.61 Billion | $3.49 Billion | $876.10 Million | 9.62x | 38.36x |
| 2023 | $26.08 Billion | $2.78 Billion | $310.30 Million | 9.40x | 84.05x |
| 2024 | $20.59 Billion | $2.78 Billion | $175.10 Million | 7.40x | 117.56x |
| 2025 | $23.20 Billion | $2.97 Billion | $265.60 Million | 7.82x | 87.35x |
Competitor Companies of 56S0 by Market Capitalization
Companies near RENAU.UNSP.ARD 1/5 EO-20 in the global market cap rankings as of October 31, 2026. See RENAU.UNSP.ARD 1/5 EO-20 net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to RENAU.UNSP.ARD 1/5 EO-20 by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #258 globally with a market cap of $99.77 Billion USD ( €85.34 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #421 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #536 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $432.01 |
| #258 | EssilorLuxottica S. A. | PA:EL | $99.77 Billion | €184.30 |
| #421 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €87.50 |
| #536 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of RENAU.UNSP.ARD 1/5 EO-20 (2022–2026)
Market capitalization of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to today. Between 2022 and today, RENAU.UNSP.ARD 1/5 EO-20's market cap moved from $33.61 Billion to $ 25.25 Billion, with a yearly change of -8.75%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €25.25 Billion | +8.82% |
| 2025 | €23.20 Billion | +12.71% |
| 2024 | €20.59 Billion | -21.07% |
| 2023 | €26.08 Billion | -22.40% |
| 2022 | €33.61 Billion | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of RENAU.UNSP.ARD 1/5 EO-20 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.02 Billion USD |
| MoneyControl | $17.02 Billion USD |
| MarketWatch | $17.02 Billion USD |
| marketcap.company | $17.02 Billion USD |
| Reuters | $17.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About RENAU.UNSP.ARD 1/5 EO-20
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more